A look inside the FDA, its recent record, and the debate over whether our nation's drug safety system is broken. Plus, FAQs and links for consumers.
Philip Hilts, author of a much-discussed new book on the FDA, talks about the agency's contentious political history -- and why defending it is "a peculiar business."
Big Pharma is one of Washington's most powerful interest groups. But are its lobbying efforts always good for business? A Web-exclusive analysis by Jonathan Cohn.
Producer Andrew Liebman offers two stories, not included in the documentary, about how drug companies have been known to handle bad news.
 
 
Funding for FRONTLINE is provided through the support of PBS
viewers. Additional support for this program is provided by the Corporation for Public Broadcasting.
Additional support is provided by U.S. News & World Report.
As medications play an ever-increasing role in modern health care, the importance of FDA approval to consumers, it would seem, has never been greater. For many consumers, the phrase "FDA approved" signifies that a drug or product is completely safe and without risk. But just how much does the average American know about the FDA approval process and what it can -- and cannot -- do? How good is the FDA's system for identifying drugs that don't work or cause harm? And what happens when a harmful product makes its way into consumers' hands? FRONTLINE investigates the FDA and drug safety, and questions whether the current system is adequate for protecting the public.
